© 2022 MJH Life Sciences and Urology Times. All rights reserved.
© 2022 MJH Life Sciences™ and Urology Times. All rights reserved.
September 08, 2022
In a phase 2 trial, patients with metastatic urothelial carcinoma and DNA repair deficiency who had not progressed on chemotherapy were randomized to either rucaparib maintenance or placebo.
May 16, 2022
Adding darolutamide to androgen deprivation therapy and docetaxel did not increase the incidence or severity of adverse events in patients with metastatic hormone-sensitive prostate cancer.
February 21, 2022
Immunotherapy with or without radiotherapy did not demonstrate significant efficacy in patients with advanced squamous cell carcinoma of the penis, according to findings from the phase 2 PERICLES trial.